Pulmatrix Inc (PULM)
2.06
+0.04
(+1.98%)
USD |
NASDAQ |
Apr 24, 16:00
2.06
0.00 (0.00%)
After-Hours: 20:00
Pulmatrix Enterprise Value: -11.80M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | -11.80M |
| April 22, 2024 | -11.81M |
| April 19, 2024 | -11.91M |
| April 18, 2024 | -12.01M |
| April 17, 2024 | -11.54M |
| April 16, 2024 | -11.43M |
| April 15, 2024 | -11.54M |
| April 12, 2024 | -11.28M |
| April 11, 2024 | -11.50M |
| April 10, 2024 | -12.23M |
| April 09, 2024 | -12.20M |
| April 08, 2024 | -12.27M |
| April 05, 2024 | -11.84M |
| April 04, 2024 | -12.31M |
| April 03, 2024 | -12.56M |
| April 02, 2024 | -12.93M |
| April 01, 2024 | -12.82M |
| March 28, 2024 | -12.78M |
| March 27, 2024 | -13.26M |
| March 26, 2024 | -13.00M |
| March 25, 2024 | -13.07M |
| March 22, 2024 | -13.07M |
| March 21, 2024 | -13.18M |
| March 20, 2024 | -13.16M |
| March 19, 2024 | -13.26M |
| Date | Value |
|---|---|
| March 18, 2024 | -13.22M |
| March 15, 2024 | -13.04M |
| March 14, 2024 | -12.80M |
| March 13, 2024 | -12.85M |
| March 12, 2024 | -12.67M |
| March 11, 2024 | -12.42M |
| March 08, 2024 | -12.20M |
| March 07, 2024 | -11.94M |
| March 06, 2024 | -12.23M |
| March 05, 2024 | -12.23M |
| March 04, 2024 | -12.34M |
| March 01, 2024 | -12.18M |
| February 29, 2024 | -11.90M |
| February 28, 2024 | -11.83M |
| February 27, 2024 | -11.69M |
| February 26, 2024 | -12.05M |
| February 23, 2024 | -12.05M |
| February 22, 2024 | -12.60M |
| February 21, 2024 | -12.64M |
| February 20, 2024 | -12.69M |
| February 16, 2024 | -12.49M |
| February 15, 2024 | -12.45M |
| February 14, 2024 | -12.64M |
| February 13, 2024 | -12.74M |
| February 12, 2024 | -12.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-33.89M
Minimum
Mar 01 2022
86.73M
Maximum
Feb 16 2021
-8.668M
Average
-13.23M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.75M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.75M |
| Oragenics Inc | 3.306M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.083M |
| Revenue (Quarterly) | 2.202M |
| Total Expenses (Quarterly) | 4.427M |
| EPS Diluted (Quarterly) | -0.57 |
| Profit Margin (Quarterly) | -94.60% |
| Earnings Yield | -187.4% |
| Normalized Earnings Yield | -187.38 |